Clinical Trial Update: Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems [Phase 2]

View source ↗

Summary

This trial update notes the completion of a Phase 2 study investigating memantine for memory, concentration, or attention problems. The sponsor is Merz Pharmace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Memory Disorders
• Subjective Cognitive Impairment

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Memory Disorder, Retention Disorder, Cognitive | Phase 2 | Status: COMPLETED